Calithera Biosciences calithera.com


Public list: BIO 2016 (619) Pharma Startups (6570) Cancer Therapeutics (1180)

Calithera Biosciences, formerly Protein Activation Therapeutics, develops therapeutic approaches to the treatment of cancer by using small molecules to activate, rather than inhibit, enzymes. The company's first program is focused on developing activators of caspases, the proteases that induce apoptosis, for the treatment of cancer. The approach of discovering activators of enzymes has the potential to be a unique and broadly applicable technology platform for developing therapies to multiple on...Show all

Calithera Biosciences, formerly Protein Activation Therapeutics, develops therapeutic approaches to the treatment of cancer by using small molecules to activate, rather than inhibit, enzymes. The company's first program is focused on developing activ...Show all

Company (IPO / Went public)

All investors data 9 Investors

Phone: 650-870-1000

Fax:

343 Oyster Point Blvd
Suite 200
 South San Francisco, 94080
 California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Calithera Biosciences $101.2M Oct 2, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Calithera Biosciences Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Board Members

Name Firm
Login to see detailsThe Column Group
Login to see detailsDelphi Ventures
Login to see detailsDelphi Ventures
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Combination therapy with glutaminase inhibitors and immuno-oncology agents Feb 01, 2019 Mar 09, 2021 Patent
Method of preparing (3r,4s)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide Nov 18, 2019 Feb 02, 2021 Patent
Compositions and methods for inhibiting arginase activity Jul 29, 2019 Feb 02, 2021 Patent
Compositions and methods for inhibiting arginase activity Aug 10, 2018 Dec 01, 2020 Patent
Compositions and methods for inhibiting arginase activity Mar 23, 2020 Nov 24, 2020 Patent
See all 38 patents